HealthCor Management, L.P. Buys Becton, Dickinson and Co, Cigna Corp, AbbVie Inc, Sells Haemonetics Corp, Teleflex Inc, Neurocrine Biosciences Inc

• New Purchases: CI, DHR, AMGN, ABT, GH, NUVA, RPRX, REGN, BNTX, ADPT, ALGN, MRK, VRTX, SDC, IMGN, ARCT, LEGN, FUSN, THC, AKUS,
• Added Positions: BDX, ABBV, ALXN, HCA, MDT, BMY, TMO, UNH, MD, LIVN, IQV, ARNA,
• Reduced Positions: NBIX, NVRO, LH, ZBH, CRL, ACAD, HUM, BPMC, EHC, BLUE, PCRX, MDGL, HZNP, AUPH,
• Sold Out: HAE, TFX, CVS, WELL, BHC, OHI, CNMD, AMRN, HOLX, BIIB, XBI, ZYME, AGIO, TEVA, NVST, RCKT, PTE,

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

1. Aurinia Pharmaceuticals Inc (AUPH) - 9,501,398 shares, 6.48% of the total portfolio. Shares reduced by 2.69%
2. Becton, Dickinson and Co (BDX) - 606,470 shares, 6.09% of the total portfolio. Shares added by 506.47%
3. Madrigal Pharmaceuticals Inc (MDGL) - 1,197,884 shares, 5.69% of the total portfolio. Shares reduced by 14.57%
4. AbbVie Inc (ABBV) - 1,317,570 shares, 5.43% of the total portfolio. Shares added by 184.02%
5. Nevro Corp (NVRO) - 1,054,103 shares, 5.28% of the total portfolio. Shares reduced by 39.86%

HealthCor Management, L.P. initiated holding in Cigna Corp. The purchase prices were between $163.84 and $215.84, with an estimated average price of $189.4. The stock is now traded at around $182.12. The impact to a portfolio due to this purchase was 3.72%. The holding were 472,360 shares as of .

HealthCor Management, L.P. initiated holding in Danaher Corp. The purchase prices were between $128.7 and $176.83, with an estimated average price of $161.23. The stock is now traded at around $207.20. The impact to a portfolio due to this purchase was 2.79%. The holding were 376,665 shares as of .

HealthCor Management, L.P. initiated holding in Amgen Inc. The purchase prices were between $197.81 and $242.74, with an estimated average price of $227.6. The stock is now traded at around $241.84. The impact to a portfolio due to this purchase was 2.57%. The holding were 259,200 shares as of .

HealthCor Management, L.P. initiated holding in Abbott Laboratories. The purchase prices were between $76.57 and $98, with an estimated average price of $90.16. The stock is now traded at around $100.97. The impact to a portfolio due to this purchase was 2.45%. The holding were 638,180 shares as of .

HealthCor Management, L.P. initiated holding in Guardant Health Inc. The purchase prices were between $60.49 and $97.5, with an estimated average price of $80.48. The stock is now traded at around $91.02. The impact to a portfolio due to this purchase was 2.45%. The holding were 718,840 shares as of .

HealthCor Management, L.P. initiated holding in NuVasive Inc. The purchase prices were between $43.51 and $66.59, with an estimated average price of $57.82. The stock is now traded at around $53.53. The impact to a portfolio due to this purchase was 2.26%. The holding were 969,580 shares as of .

HealthCor Management, L.P. added to a holding in Becton, Dickinson and Co by 506.47%. The purchase prices were between $225.4 and $270, with an estimated average price of $246.67. The stock is now traded at around $263.80. The impact to a portfolio due to this purchase was 5.09%. The holding were 606,470 shares as of .

HealthCor Management, L.P. added to a holding in AbbVie Inc by 184.02%. The purchase prices were between $73.37 and $98.18, with an estimated average price of $87.8. The stock is now traded at around $95.67. The impact to a portfolio due to this purchase was 3.52%. The holding were 1,317,570 shares as of .

HealthCor Management, L.P. added to a holding in Alexion Pharmaceuticals Inc by 349.52%. The purchase prices were between $89.77 and $119.9, with an estimated average price of $105.7. The stock is now traded at around $103.74. The impact to a portfolio due to this purchase was 2.44%. The holding were 666,510 shares as of .

HealthCor Management, L.P. added to a holding in HCA Healthcare Inc by 248.80%. The purchase prices were between $81.83 and $118.04, with an estimated average price of $103.85. The stock is now traded at around $133.79. The impact to a portfolio due to this purchase was 2.33%. The holding were 801,290 shares as of .

HealthCor Management, L.P. added to a holding in Medtronic PLC by 174.63%. The purchase prices were between $84.11 and $103.33, with an estimated average price of $95.86. The stock is now traded at around $101.70. The impact to a portfolio due to this purchase was 2.24%. The holding were 915,440 shares as of .

HealthCor Management, L.P. added to a holding in Bristol-Myers Squibb Company by 509.37%. The purchase prices were between $54.82 and $64.09, with an estimated average price of $59.75. The stock is now traded at around $63.11. The impact to a portfolio due to this purchase was 2.19%. The holding were 1,062,500 shares as of .

HealthCor Management, L.P. sold out a holding in Haemonetics Corp. The sale prices were between $84.96 and $118.91, with an estimated average price of $101.09.

HealthCor Management, L.P. sold out a holding in Teleflex Inc. The sale prices were between $279.8 and $376.58, with an estimated average price of $344.67.

HealthCor Management, L.P. sold out a holding in CVS Health Corp. The sale prices were between $55.41 and $70.62, with an estimated average price of $62.88.

HealthCor Management, L.P. sold out a holding in Welltower Inc. The sale prices were between $37.26 and $61.65, with an estimated average price of $49.19.

HealthCor Management, L.P. sold out a holding in Bausch Health Companies Inc. The sale prices were between $13.31 and $20.51, with an estimated average price of $17.6.

HealthCor Management, L.P. sold out a holding in Omega Healthcare Investors Inc. The sale prices were between $24.1 and $34.89, with an estimated average price of $29.65.